From left, Robert Bolluyt, DHA Component Acquisition Executive, Bob Charles, Chief, Medical Research Law, Office of the Staff Judge Advocate, USAMRDC, and Elise Huszar, President and CEO of The Geneva Foundation participate in the Master CRADA signing.
Bethesda, MD – The Geneva Foundation, together with The Henry M. Jackson Foundation and The Metis Foundation, has participated in the signing of a Master Cooperative Research and Development Agreement (Master CRADA) with the Defense Health Agency (DHA). This event occurred on Wednesday, 26 July 2023, marking a significant milestone in advancing research and development in the military medical enterprise.
The Master CRADA is the culmination of a collaborative effort between the three leading foundations to identify and address key roadblocks encountered during research at Military Treatment Facilities (MTFs). With the invaluable support and coordination from DHA’s Clinical Investigation Program (CIP) leadership and the Office of the Staff Judge Advocate, Geneva and its partner foundations jointly drafted standardized legal provisions and terms for the agreement.
“The signing of the Master CRADA underscores the remarkable dedication and collective efforts made by all involved parties,” said Elise Huszar, President and Chief Executive Officer of The Geneva Foundation. “It exemplifies the mutual commitment of the nonprofit foundations and the Defense Health Agency to streamline R&D activities to accelerate medical innovation and discoveries for our service members and the communities they serve.”
Under this Master CRADA, each foundation individually executed an agreement with the DHA, streamlining the research process and providing a robust framework for conducting medical research at MTFs. This approach is expected to catalyze advancements in military medicine and save lives worldwide.
During the Master CRADA signing ceremony, Bob Charles, Chief, Medical Research Law, Office of the Staff Judge Advocate, U.S. Army Medical Research & Development Command (USAMRDC), commended the nonprofit foundations, stating, “The nonprofit foundations have the same passion for the service member and DHA beneficiaries as those within the ‘inside’— it is a mission thing. The nonprofits are making a difference in a world that is near and dear to our hearts.”
Elise Huszar emphasized the significance of the collaboration, remarking, “This collaboration marks the first time the foundations have united to enhance the Military Health System research community. We pledge ongoing collaboration among foundations, sharing resources and best practices, and look forward to a future of continued advancements in partnership with the DHA.”
About The Geneva Foundation
The Geneva Foundation is a leading 501(c)3 nonprofit dedicated to advancing military medicine through cutting-edge research, development, and education. With a significant presence in the United States and around the globe, our agile approach allows us to provide full-spectrum scientific, technical, and program management expertise in federal grants, industry-sponsored clinical trials, and federal contracts. As a trusted partner, we contribute to the mission of enhancing health and well-being for service members and their communities, driving transformative outcomes for the future of military healthcare. www.genevaUSA.org